{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:43:38Z","timestamp":1774579418437,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Laboratorios Columbia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05139-8","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:43:52Z","timestamp":1762523032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review and meta-analysis of bioactive hydrolysates derived from Saccharomyces cerevisiae on obesity management"],"prefix":"10.1186","volume":"25","author":[{"given":"A.A.","family":"Palacios-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V.","family":"Yamamoto-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Abreu-Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moreno-Higareda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cer\u00f3n-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ram\u00edrez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"5139_CR1","unstructured":"Ng M, Gakidou E, Lo J, Abate YH, Abbafati C, Abbas N et al. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet [Internet]. 2025;405(10481):813\u201338. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673625003551"},{"key":"5139_CR2","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol [Internet]. 2025; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39824205"},{"key":"5139_CR3","doi-asserted-by":"crossref","unstructured":"Ch\u00e1vez-Manzanera EA, Vera-Zertuche JM, Kaufer-Horwitz M, V\u00e1zquez-Vel\u00e1zquez V, Flores-L\u00e1zaro JR, Mireles-Zavala L, et al. Mexican clinical practice guidelines for adult overweight and obesity management. Current Obesity Reports. Springer; 2024.","DOI":"10.1007\/s13679-024-00585-w"},{"key":"5139_CR4","doi-asserted-by":"crossref","unstructured":"Gaskin CJ, Cooper K, Stephens LD, Peeters A, Salmon J, Porter J. Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review. Obesity Reviews. Volume 25. John Wiley and Sons Inc; 2024.","DOI":"10.1111\/obr.13700"},{"issue":"12","key":"5139_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","volume":"18","author":"D Eisenberg","year":"2022","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American society for metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345\u201356.","journal-title":"Surg Obes Relat Dis"},{"key":"5139_CR6","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1210\/clinem\/dgab091","volume":"106","author":"K Kheniser","year":"2021","unstructured":"Kheniser K, Saxon DR, Kashyap SR. Long-Term weight loss strategies for obesity. J Clin Endocrinol Metabolism Endocr Soc. 2021;106:1854\u201366.","journal-title":"J Clin Endocrinol Metabolism Endocr Soc"},{"issue":"5","key":"5139_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","volume":"163","author":"E Grunvald","year":"2022","unstructured":"Grunvald E, Shah R, Hernaez R, Chandar AK, Pickett-Blakely O, Teigen LM, et al. AGA clinical practice guideline on Pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198\u2013225.","journal-title":"Gastroenterology"},{"key":"5139_CR8","unstructured":"Congressional Budget Office, Washington DC. Congressional Budget Office. 2024 [cited 2025 Apr 9]. How Would Authorizing Medicare to Cover Anti-Obesity Medications Affect the Federal Budget? Available from: https:\/\/www.cbo.gov\/publication\/60816"},{"key":"5139_CR9","doi-asserted-by":"crossref","unstructured":"Puri V, Nagpal M, Singh I, Singh M, Dhingra GA, Huanbutta K, et al. A comprehensive review on nutraceuticals: therapy support and formulation challenges. Volume 14. Nutrients. MDPI; 2022.","DOI":"10.3390\/nu14214637"},{"key":"5139_CR10","doi-asserted-by":"crossref","unstructured":"Alali M, Alqubaisy M, Aljaafari MN, Alali AO, Baqais L, Molouki A, et al. Nutraceuticals: transformation of conventional foods into health promoters\/disease preventers and safety considerations. Volume 26. Molecules. MDPI AG; 2021.","DOI":"10.3390\/molecules26092540"},{"key":"5139_CR11","volume-title":"Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis of 111 randomized clinical trials","author":"H Shahinfar","year":"2023","unstructured":"Shahinfar H, Jayedi A, Torabynasab K, Payandeh N, Martami F, Moosavi H, et al. Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis of 111 randomized clinical trials. Volume 196. Pharmacological Research: Academic; 2023."},{"key":"5139_CR12","doi-asserted-by":"crossref","unstructured":"Santamarina AB, Nehmi Filho V, de Freitas JA, Silva BFRB da, Gusm\u00e3o AF, Olivieri EHR et al. Nutraceutical composition (yeast \u03b2-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: A randomized pilot study. Clin Nutr ESPEN. 2024;63:476\u201390.","DOI":"10.1016\/j.clnesp.2024.06.033"},{"issue":"1","key":"5139_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.nut.2013.02.009","volume":"30","author":"EY Jung","year":"2014","unstructured":"Jung EY, Cho MK, Hong YH, Kim JH, Park Y, Chang UJ, et al. Yeast hydrolysate can reduce body weight and abdominal fat accumulation in obese adults. Nutrition. 2014;30(1):25\u201332.","journal-title":"Nutrition"},{"key":"5139_CR14","doi-asserted-by":"crossref","unstructured":"Spigoni V, Aldigeri R, Antonini M, Micheli MM, Fantuzzi F, Fratter A et al. Effects of a new nutraceutical formulation (Berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: Results from a randomized, double blind, placebo-controlled study. Int J Mol Sci. 2017;18(7).","DOI":"10.3390\/ijms18071498"},{"issue":"7","key":"5139_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12071960","volume":"12","author":"M Valero-P\u00e9rez","year":"2020","unstructured":"Valero-P\u00e9rez M, Bermejo LM, L\u00f3pez-Plaza B, Garc\u00eda MA, Palma-Milla S, G\u00f3mez-Candela C. Regular consumption of LIPIGO\u00ae promotes the reduction of body weight and improves the rebound effect of obese people undergo a comprehensive weight loss program. Nutrients. 2020;12(7):1\u201314.","journal-title":"Nutrients"},{"issue":"12","key":"5139_CR16","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1002\/jsfa.8301","volume":"97","author":"J Santas","year":"2017","unstructured":"Santas J, L\u00e1zaro E, Cu\u00f1\u00e9 J. Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGo\u00ae) in body weight loss: randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults. J Sci Food Agric. 2017;97(12):4250\u20137.","journal-title":"J Sci Food Agric"},{"issue":"2","key":"5139_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/19390211.2016.1207005","volume":"14","author":"K Mosikanon","year":"2017","unstructured":"Mosikanon K, Arthan D, Kettawan A, Tungtrongchitr R, Prangthip P. Yeast \u03b2\u2013Glucan modulates inflammation and waist circumference in overweight and obese subjects. J Diet Suppl. 2017;14(2):173\u201385.","journal-title":"J Diet Suppl"},{"key":"5139_CR18","doi-asserted-by":"crossref","unstructured":"Nehmi-Filho V, Santamarina AB, de Freitas JA, Trarbach EB, de Oliveira DR, Palace-Berl F et al. Novel nutraceutical supplements with yeast \u03b2-glucan, prebiotics, minerals, and Silybum Marianum (silymarin) ameliorate obesity-related metabolic and clinical parameters: A double-blind randomized trial. Front Endocrinol (Lausanne). 2023;13.","DOI":"10.3389\/fendo.2022.1089938"},{"issue":"1","key":"5139_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3746\/pnf.2017.22.1.45","volume":"22","author":"EY Jung","year":"2017","unstructured":"Jung EY, Lee JW, Hong YH, Chang UJ, Suh HJ. Low dose yeast hydrolysate in treatment of obesity and weight loss. Prev Nutr Food Sci. 2017;22(1):45\u20139.","journal-title":"Prev Nutr Food Sci"},{"issue":"2","key":"5139_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1745-4514.2010.00385.x","volume":"35","author":"EY Jung","year":"2011","unstructured":"Jung EY, Kim SY, Bae SH, Chang UJ, Choi JW, Suh HJ. Weight reduction effects of yeast hydrolysate below 10\u00a0kDa on obese young women. J Food Biochem. 2011;35(2):337\u201350.","journal-title":"J Food Biochem"},{"key":"5139_CR21","volume-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Volume 372. The BMJ: BMJ Publishing Group; 2021."},{"key":"5139_CR22","unstructured":"The Cochrane Collaboration. Review manager (RevMan). The Cochrane Collaboration; 2025."},{"key":"5139_CR23","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019.","DOI":"10.1136\/bmj.l4898"},{"key":"5139_CR24","unstructured":"Portbital. https:\/\/plotdigitizer.com.2025. PlotDigitizer 3.1.6."},{"issue":"12","key":"5139_CR25","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.3390\/nu13124250","volume":"13","author":"MM Canaan","year":"2021","unstructured":"Canaan MM, Reis-Canaan JC, Zanger\u00f4nimo MG, Andrade EF, Gon\u00e7alves TMSV, Pereira MCA, et al. Yeast Beta-Glucans ingestion does not influence body weight: A systematic review and Meta-Analysis of Pre-Clinical studies. Nutrients. 2021;13(12):4250.","journal-title":"Nutrients"},{"key":"5139_CR26","doi-asserted-by":"crossref","unstructured":"Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. The Lancet. Volume 403. Elsevier B.V.; 2024. pp. e21\u201331.","DOI":"10.1016\/S0140-6736(24)00351-9"},{"key":"5139_CR27","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.phrs.2024.107398","volume":"208","author":"V Musazadeh","year":"2024","unstructured":"Musazadeh V, Assadian K, Rajabi F, Faghfouri AH, Soleymani Y, Kavyani Z, et al. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2024;208:107398.","journal-title":"Pharmacol Res"},{"key":"5139_CR28","doi-asserted-by":"crossref","unstructured":"Musazadeh V, Mohammadi Anilou M, Vajdi M, Karimi A, Sedgh Ahrabi S, Dehghan P. Effects of synbiotics supplementation on anthropometric and lipid profile parameters: finding from an umbrella meta-analysis. Front Nutr. 2023;10.","DOI":"10.3389\/fnut.2023.1121541"},{"issue":"3","key":"5139_CR29","first-page":"262","volume":"17","author":"KB Hong","year":"2015","unstructured":"Hong KB, Jung EY, Kim JH, Chang UJ, Suh HJ. Yeast hydrolysate as a functional anti-obesity ingredient: appetite suppressive effects of yeast hydrolysate in food deprived mice. Progress Nutr. 2015;17(3):262\u20134.","journal-title":"Progress Nutr"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05139-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05139-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05139-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:43:57Z","timestamp":1762523037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05139-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5139"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05139-8","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Palacios-Garc\u00eda AA and Moreno-Higareda R, are full time employees of Laboratorios Columbia. Cer\u00f3n-Trujillo B holds shares at Aequitas Medica. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}